U.S. Markets open in 1 hr 54 mins

Novavax R&D President discusses progress of coronavirus vaccine

Shares of biotech firm Novavax are soaring this week following the announcement of the company is working on developing a vaccine for the deadly China virus. Novavax President of Research & Development Dr. Greg Glenn joins Seana Smith on The Ticker to discuss.